MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases
Article first published online: 30 SEP 2013
© 2013 Wiley Periodicals, Inc.
Volume 74, Issue 1, pages 103–111, January 2014
How to Cite
Flatley, B., Wilmott, K. G., Malone, P. and Cramer, R. (2014), MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases. Prostate, 74: 103–111. doi: 10.1002/pros.22736
- Issue published online: 6 DEC 2013
- Article first published online: 30 SEP 2013
- Manuscript Accepted: 9 SEP 2013
- Manuscript Received: 2 JUL 2013
Additional supporting information may be found in the online version of this article at the publisher's web-site.
|pros22736-sm-0001-SuppTab-S1.tif||935K||Table SI. Meta-Data of Study Participants|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.